Word

AWEDIO

Status

Pending

Status Code

732

Status Date

Tuesday, February 27, 2024

Serial Number

97266337

Mark Type

4000

Filing Date

Monday, February 14, 2022

Published for Opposition

Tuesday, July 12, 2022

Trademark Owner History

Astellas Pharma Inc. - Owner At Publication

Classifications

9 Downloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, PDAs and mobile phones, namely, software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological medical indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers

Trademark Events

Feb 28, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 27, 2024

Sou Extension 3 Granted

Feb 27, 2024

Sou Extension 3 Filed

Feb 27, 2024

Sou Teas Extension Received

Sep 1, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 30, 2023

Sou Extension 2 Granted

Aug 30, 2023

Sou Extension 2 Filed

Aug 30, 2023

Sou Teas Extension Received

Oct 4, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 30, 2022

Sou Extension 1 Granted

Sep 30, 2022

Sou Extension 1 Filed

Sep 30, 2022

Sou Teas Extension Received

Sep 6, 2022

Noa E-Mailed - Sou Required From Applicant

Jul 12, 2022

Official Gazette Publication Confirmation E-Mailed

Jul 12, 2022

Published For Opposition

Jun 22, 2022

Notification Of Notice Of Publication E-Mailed

Jun 8, 2022

Approved For Pub - Principal Register

Jun 7, 2022

Teas/Email Correspondence Entered

Jun 7, 2022

Correspondence Received In Law Office

Jun 7, 2022

Teas Response To Office Action Received

Apr 20, 2022

Notification Of Non-Final Action E-Mailed

Apr 20, 2022

Non-Final Action E-Mailed

Apr 20, 2022

Non-Final Action Written

Apr 14, 2022

Assigned To Examiner

Feb 18, 2022

New Application Office Supplied Data Entered

Feb 17, 2022

New Application Entered